Kymera Therapeutics, Inc. ($KYMR)
Filing Information
| Accession Number | 0001193125-26-242266 |
|---|---|
| Form Type | 4 |
| Filing Date | May 27, 2026 |
| Document | View SEC Filing |
Transactions
7
Total Shares
17,184
Total Value
$1,373,289.53
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer | Common Stock | โ | May 26, 2026 | Sale | 3,730 | $78.36 | $292,271.24 | 57,472 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | May 26, 2026 | Sale | 324 | $79.17 | $25,651.08 | 57,148 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | May 26, 2026 | Sale | 3,800 | $79.39 | $301,690.74 | 53,348 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | May 26, 2026 | Sale | 4,500 | $80.02 | $360,110.70 | 48,848 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | May 26, 2026 | Sale | 551 | $80.71 | $44,470.22 | 48,297 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | May 27, 2026 | Sale | 3,679 | $81.50 | $299,849.54 | 44,618 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | May 27, 2026 | Sale | 600 | $82.08 | $49,246.02 | 44,018 | Direct | โ | View Details |